About LiGalli
LiGalli is a company based in The Hague (Netherlands) founded in 2014 by Willem de Laat. It operates as a D2C and B2B. LiGalli offers products and services including MedRing, Smartphone Companion App, and Cloud Data Platform. LiGalli operates in a competitive market with competitors including Baby-Scan, Novuqare and Nutricia Flocare, among others.
- Headquarter The Hague, Netherlands
- Founders Willem de Laat
- SectorsHealthcare
- Email••••••••
- Website ligalli.health
- Social LinkedIn
- Legal Name Ligalli B.V.
Products & Services of LiGalli
LiGalli offers a comprehensive portfolio of products and services, including MedRing, Smartphone Companion App, and Cloud Data Platform.
Personalized device for scheduled vaginal drug delivery and bio signal monitoring.
App to schedule drug delivery and collect treatment insights.
Platform for collecting and optimizing health data from devices.
People of LiGalli
1 people are tracked at LiGalli (1 in leadership).
| Name | Role | Group |
|---|---|---|
Willem de Laat | Founder, CEO | Leadership |
Complete people profiles for LiGalli
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of LiGalli
LiGalli operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Baby-Scan, Novuqare and Nutricia Flocare, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| baby-scan.com | 2015 | Veldhoven, Netherlands | – | – | Delivers wireless ultrasound scanners for monitoring unborn babies. | |
| novuqare.com | 2012 | Rosmalen, Netherlands | – | – | Develops EMG systems for accurate pelvic floor therapy and diagnosis. | |
| nutriciaflocare.com | 2008 | Amsterdam, Netherlands | – | – | Offers pumps, tubes, and sets for enteral nutrition and medical device support. |
Detailed competitors of LiGalli
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to LiGalli
10 companies that operate in the same segment as LiGalli (Health Monitoring & Wearables), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Smart fitness equipment and streaming platforms are provided. | 2011 | New York, New York, United States | USD 995.53 M | USD 2.45 B | 2,660 | |
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
Internet first brand offering wearable breast pumps | 2013 | London, England, United Kingdom | USD 157.63 M | – | – | |
Metabolic health is tracked via devices and fitness platforms. | 2019 | Bengaluru, Karnataka, India | USD 163.28 M | USD 65.48 M | 274 | |
Health-tracking smart rings and biosensors are developed for biometric monitoring. | 2013 | Oulu, North Ostrobothnia, Finland | USD 1.32 B | – | – | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
AI-based mobile app tracks and predicts menstrual cycles. | 2015 | London, England, United Kingdom | USD 269 M | – | – | |
Smartphone-enabled glucometers and diabetes management apps are provided. | 2015 | Delhi, Delhi, India | USD 50.83 M | USD 2.74 M | 142 | |
Provider of a fertility tracking app that doubles as birth control | 2013 | Stockholm, Sweden | USD 99.5 M | – | – | |
Diabetes management is enabled via glucose meters and mobile apps. | 2010 | Palo Alto, California, United States | USD 201 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about LiGalli
LiGalli was founded in 2014.
LiGalli is headquartered in The Hague, Netherlands. It is registered at The Hague, South Holland, Netherlands.
Willem de Laat is the current CEO of LiGalli. They have also founded this company.
LiGalli specializes in intelligent drug delivery and diagnostics, focusing on womens health through the MedRing device, which administers drugs on a programmable schedule and monitors bio signals via the vagina. It includes a smartphone app for scheduling and a cloud platform for data collection, aiding therapy compliance. Based in Leiden, The Netherlands, the company collaborates with healthcare professionals to improve treatments for patients.
LiGalli's top competitors include Baby-Scan, Novuqare and Nutricia Flocare.
LiGalli offers MedRing, Smartphone Companion App, and Cloud Data Platform.
LiGalli operates through Ligalli B.V..